D.A. Davidson & Co. Merck & Co., Inc. Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 547,457 shares of MRK stock, worth $62.2 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

547,457

Previous 551,083 0.66%

Holding current value

$62.2 Million

Previous $72.7 Million 6.79%

% of portfolio

0.61%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $448,898 - $482,112	-3,626 Reduced 0.66%	547,457 $67.8 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $1.15 Million - $1.34 Million	-10,129 Reduced 1.8%	551,083 $72.7 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $3.81 Million - $4.15 Million	-38,035 Reduced 6.35%	561,212 $61.2 Million
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $210,326 - $233,576	-2,043 Reduced 0.34%	599,247 $61.7 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $831,952 - $906,790	-7,660 Reduced 1.26%	601,290 $69.4 Million
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $1.42 Million - $1.58 Million	-13,785 Reduced 2.21%	608,950 $64.8 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $1.98 Million - $2.54 Million	-22,630 Reduced 3.51%	622,735 $69.1 Million
Q3 2022 Nov 07, 2022	BUY	$84.53 - $94.96 $4.06 Million - $4.56 Million	48,037 Added 8.04%	645,365 $55.6 Million
Q2 2022 Jul 28, 2022	SELL	$83.49 - $94.64 $1.07 Million - $1.22 Million	-12,856 Reduced 2.11%	597,328 $54.5 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $308,447 - $345,750	4,196 Added 0.69%	610,184 $50.1 Million
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $691,936 - $866,739	9,573 Added 1.61%	605,988 $46.5 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $2.75 Million - $3.03 Million	38,382 Added 6.88%	596,415 $44.8 Million
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $2.15 Million - $2.38 Million	30,627 Added 5.81%	558,033 $43.4 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $20.8 Million - $24.5 Million	302,184 Added 134.17%	527,406 $40.7 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $762,556 - $846,281	10,625 Added 4.95%	225,222 $18.4 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $102,817 - $116,544	-1,405 Reduced 0.65%	214,597 $17.8 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $18.8 Million - $21.4 Million	-267,161 Reduced 55.29%	216,002 $16.7 Million
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $354,752 - $491,704	5,599 Added 1.17%	483,163 $37.2 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $1.18 Million - $1.33 Million	15,230 Added 3.29%	477,564 $43.4 Million
Q3 2019 Nov 05, 2019	SELL	$76.08 - $82.93 $3.28 Million - $3.58 Million	-43,154 Reduced 8.54%	462,334 $38.9 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $7.3 Million - $8.53 Million	-104,557 Reduced 17.14%	505,488 $42.4 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $1.64 Million - $1.87 Million	-23,540 Reduced 3.72%	610,045 $50.4 Million
Q4 2018 Jan 29, 2019	SELL	$65.24 - $75.71 $994,779 - $1.15 Million	-15,248 Reduced 2.35%	633,585 $48.4 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $26,248 - $30,867	455 Added 0.07%	648,833 $46 Million
Q2 2018 Aug 02, 2018	BUY	$50.83 - $59.72 $581,647 - $683,375	11,443 Added 1.8%	648,378 $39.4 Million
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $1.3 Million - $1.51 Million	25,447 Added 4.16%	636,935 $34.7 Million
Q4 2017 Feb 08, 2018	BUY	$51.62 - $61.64 $4.49 Million - $5.36 Million	87,007 Added 16.59%	611,488 $34.4 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $4.77 Million - $5.13 Million	81,290 Added 18.34%	524,481 $33.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	443,191	443,191 $0

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account